SYNTHESIS OF BIOACTIVE COMPLEX ALKALOIDS
生物活性复合生物碱的合成
基本信息
- 批准号:7372447
- 负责人:
- 金额:$ 39.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-04-10 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAlder plantAlkaloidsAntifungal AgentsAntiviral AgentsArchitectureAreaBindingBiologicalBiological FactorsCancer cell lineCarbodiimidesCellsClassColon CarcinomaComplexCyclopentaneCytotoxic AntibioticsCytotoxinDNA Sequence RearrangementDevelopmentDissociationEvaluationExhibitsFacility Construction Funding CategoryFamilyFamily memberFoundationsGenerationsGoalsGuanidinesHIVHIV Envelope Protein gp120HealthHumanHuman BiologyImidatesImidazoleIminesImmunosuppressive AgentsInhibitory Concentration 50InvestigationIon ChannelLethal Dose 50Malignant Epithelial CellMedicineMethodsMusNitrogenOrganic ChemistryPalau&aposaminePrincipal InvestigatorProcessProtein Tyrosine KinasePyrimidinePyrimidinesPyrrolesReactionResearchTherapeuticTherapeutic AgentsToxic effectchemical synthesiscrambescidin 816cycloadditioncylindrospermopsincytotoxiccytotoxicityguanidiniumimmunoregulationinnovationinterestion channel blockerleukemiamarine natural productmembernovelprogramsresponsesmall molecule
项目摘要
DESCRIPTION (provided by applicant): This research program focuses on the development of new synthetic strategies for the total synthesis of biologically active complex alkaloid natural products. Within each total synthesis goal lies the implicit aim of discovering and exploiting new reactions that push the boundaries of chemical synthesis innovation. In this context, new strategies for the total synthesis of several guanidine-containing complex alkaloids will be explored. These classes of targets include the family of anti-HIV/immunomodulating batzelladine alkaloids, the family of anticancer and ion-channel disrupting crambescidin alkaloids, the potent cytotoxin cylindrospermopsin, and the powerful immunosuppressant palau'amine. All of these natural products exhibit significant yet distinct biological responses, yet they are all structurally characterized by at least one guanidine moiety embedded within a complex polycyclic architecture, a synthetic challenge that will be addressed by investigating novel annulation strategies and reactions for nitrogen-heterocycle synthesis. These proposed goals will involve investigation of diastereoselective [4+2]-annulation of vinyl carbodiimides with chiral imine and imidate derivatives for dihydropyrimidine and pyrimidine synthesis, as well as other convergent cycloaddition strategies for the construction of fully substituted all-cis cyclopentanes. Successful synthesis of these target molecules will not only lay the foundation of efficient and practical strategies for complex alkaloid synthesis, but also provide access to complex natural products of biological interest and therapeutic potential in a variety of health areas, including small molecule cytotoxic/anticancer, antiviral, and immunomodulating agents, as well as unique heterocyclic constructs that specifically disrupt ion channel function.
描述(由申请人提供):该研究计划的重点是开发新的合成策略,以全合成生物活性复杂的生物碱天然产物。在每个总合成目标中,目标是发现和利用推动化学合成创新边界的新反应的隐含目的。在这种情况下,将探讨几种含鸟嘌呤复合体生物碱的总合成的新策略。这些目标类别包括抗HIV/免疫调节的蝙蝠碱生物碱,抗癌家族和离子通道家族,破坏了crambesscidin生物碱,有效的细胞毒素cylindrospermopsin,以及强大的免疫抑制剂palau'amamine。所有这些天然产物都表现出显着但不同的生物学反应,但它们在结构上的特征都至少具有嵌合在复杂的多环结构中的鸟胺部分,这是一种合成的挑战,该挑战将通过研究氮基因核合成的新型环状策略和反应来解决。这些提出的目标将涉及对二氢酰亚胺和二氢吡啶的合成以及其他融合的环载策略的非对映选择性[4+2]的乙烯基碳二酰亚胺的施加,并拟胺的衍生物用于二氢吡啶胺和吡啶胺的合成。 Successful synthesis of these target molecules will not only lay the foundation of efficient and practical strategies for complex alkaloid synthesis, but also provide access to complex natural products of biological interest and therapeutic potential in a variety of health areas, including small molecule cytotoxic/anticancer, antiviral, and immunomodulating agents, as well as unique heterocyclic constructs that specifically disrupt ion channel function.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Y Gin其他文献
David Y Gin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Y Gin', 18)}}的其他基金
Synthesis of Carbohydrate Immunostimulating Agents
碳水化合物免疫刺激剂的合成
- 批准号:
7145928 - 财政年份:1999
- 资助金额:
$ 39.9万 - 项目类别:
Synthesis of Carbohydrate Immunostimulating Agents
碳水化合物免疫刺激剂的合成
- 批准号:
6845359 - 财政年份:1999
- 资助金额:
$ 39.9万 - 项目类别:
SYNTHESIS OF CARBOHYDRATE IMMUNOSTIMULATING AGENTS
碳水化合物免疫刺激剂的合成
- 批准号:
2741895 - 财政年份:1999
- 资助金额:
$ 39.9万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Small molecule modulation of 14-3-3 protein-protein interactions
14-3-3 蛋白质-蛋白质相互作用的小分子调节
- 批准号:
10607941 - 财政年份:2023
- 资助金额:
$ 39.9万 - 项目类别:
Synthesis and non-chromatographic purification of long RNA oligonucleotides containing naturally occurring modification
含有天然修饰的长 RNA 寡核苷酸的合成和非色谱纯化
- 批准号:
10364172 - 财政年份:2022
- 资助金额:
$ 39.9万 - 项目类别:
Total Synthesis of Keramaphidin B via an Azacyclic Allene Intermediate
通过氮杂环丙二烯中间体全合成 Keramaphidin B
- 批准号:
10220854 - 财政年份:2020
- 资助金额:
$ 39.9万 - 项目类别:
Chemistry and Pharmacology of Iboga Alkaloids
Iboga 生物碱的化学和药理学
- 批准号:
10179354 - 财政年份:2020
- 资助金额:
$ 39.9万 - 项目类别:
Chemistry and Pharmacology of Iboga Alkaloids
Iboga 生物碱的化学和药理学
- 批准号:
10370433 - 财政年份:2020
- 资助金额:
$ 39.9万 - 项目类别: